Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

EGRX Eagle Pharmaceuticals Inc

2,14

0,00 (0,00%)

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Eagle Pharmaceuticals Charts.

Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Eagle Pharmaceuticals Charts.

News Eagle Pharmaceuticals Inc

Form 3 - Initial statement of beneficial ownership of securities
Mittwoch 20 November 2024 (6 Tage vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Mittwoch 13 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Dienstag 12 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 12 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mittwoch 9 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Dienstag 8 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 2 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 27 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Freitag 9 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 5 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 10 Juli 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere Eagle Pharmaceuticals Inc News-Artikel

Equity Lifestyle Propert...

Societe Generale Effekten

Agf Elements Global Port...

Ivz Ust 1-3 Gbh

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen